Arax Advisory Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-367
Closed -$37.3K 3975
2025
Q4
$37.3K Sell
367
-20,746
-98% -$1.67M ﹤0.01% 1767
2025
Q3
$1.16M Buy
21,113
+20,934
+11,695% +$1.05M 0.02% 606
2025
Q2
$9.51K Buy
179
+135
+307% +$6.86K ﹤0.01% 1987
2025
Q1
$1.91K Buy
44
+40
+1,000% +$2.03K ﹤0.01% 2085
2024
Q4
$225 Sell
4
-11
-73% -$685 ﹤0.01% 2385
2024
Q3
$1.02K Buy
+15
New +$847 ﹤0.01% 2251

Other funds holding EXAS

Arax Advisory Partners's EXAS Position: Q1 2026 in Review

Arax Advisory Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 367 shares — an estimated $37.3K sold.

Arax Advisory Partners first reported a position in EXAS in Q3 2024 and held it in 6 quarters. The position peaked at $1.16M in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Arax Advisory Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Arax Advisory Partners sold 367 Exact Sciences shares in Q1 2026, an estimated $37.3K.
  • Arax Advisory Partners first reported a position in Exact Sciences in Q3 2024 and held it in 6 quarters.
  • Arax Advisory Partners's Exact Sciences position peaked at $1.16M in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.